Insider Stock Trading History of Gorman Kevin Charles


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gorman Kevin Charles since year 2005. The trader's CIK number is 1201096. At the time of this reporting, Gorman Kevin Charles is the Chief Executive Officer of Neurocrine Biosciences Inc . (stock ticker symbol NBIX). See this page for all insider trading activities at Neurocrine Biosciences Inc .


Stock purchases, sales, and option exercises reported by insider Gorman Kevin Charles since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-16 NBIX Neurocrine Biosciences Inc Sale 3,750 78.89 295,818
2017-05-02 NBIX Neurocrine Biosciences Inc Option Ex 21,739 2.59 56,304
2017-05-02 NBIX Neurocrine Biosciences Inc Sale 21,739 53.23 1,157,166
2017-04-12 NBIX Neurocrine Biosciences Inc Sale 19,596 50.82 995,868
2017-02-06 NBIX Neurocrine Biosciences Inc Sale 3,010 43.18 129,971
2017-02-08 NBIX Neurocrine Biosciences Inc Option Ex 64,161 2.59 166,176
2017-02-03 NBIX Neurocrine Biosciences Inc Sale 3,125 42.55 132,968
2017-01-17 NBIX Neurocrine Biosciences Inc Sale 3,750 40.65 152,437
2017-01-10 NBIX Neurocrine Biosciences Inc Sale 3,750 43.28 162,300
2016-12-23 NBIX Neurocrine Biosciences Inc Option Ex 9,100 2.59 23,569
2016-02-03 NBIX Neurocrine Biosciences Inc Sale 3,125 38.04 118,875
2016-01-19 NBIX Neurocrine Biosciences Inc Sale 3,750 46.70 175,125
2016-01-11 NBIX Neurocrine Biosciences Inc Sale 3,750 44.17 165,637
2015-10-16 NBIX Neurocrine Biosciences Inc Sale 33,500 47.77 1,600,295
2015-03-24 NBIX Neurocrine Biosciences Inc Sale 40,000 41.53 1,661,200
2015-03-24 NBIX Neurocrine Biosciences Inc Option Ex 40,000 2.59 103,600
2015-01-16 NBIX Neurocrine Biosciences Inc Sale 3,750 30.79 115,462
2015-01-12 NBIX Neurocrine Biosciences Inc Sale 3,750 28.43 106,612
2015-01-08 NBIX Neurocrine Biosciences Inc Option Ex 25,000 2.59 64,750
2015-01-08 NBIX Neurocrine Biosciences Inc Sale 25,000 27.39 684,750
2014-12-18 NBIX Neurocrine Biosciences Inc Sale 55,000 23.24 1,278,200
2014-12-19 NBIX Neurocrine Biosciences Inc Sale 15,000 24.01 360,150
2014-12-18 NBIX Neurocrine Biosciences Inc Option Ex 70,000 4.28 299,390
2014-01-10 NBIX Neurocrine Biosciences Inc Sale 3,750 18.57 69,637
2014-01-07 NBIX Neurocrine Biosciences Inc Sale 108,000 16.76 1,810,080
2011-02-28 NBIX Neurocrine Biosciences Inc Sale 15,400 6.83 105,135
2010-03-01 NBIX Neurocrine Biosciences Inc Sale 15,609 2.53 39,490
2010-01-12 NBIX Neurocrine Biosciences Inc Sale 9,445 2.52 23,829
2009-03-30 NBIX Neurocrine Biosciences Inc Sale 15,146 3.43 51,920
2009-01-13 NBIX Neurocrine Biosciences Inc Sale 9,195 3.37 31,005
2008-02-12 NBIX Neurocrine Biosciences Inc Sale 8,230 5.03 41,372
2005-12-08 NBIX Neurocrine Biosciences Inc Sale 3,000 62.85 188,547

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gorman Kevin Charles (Chief Executive Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.